Aminopyrimidine kinase inhibitors

摘要

Disclosed are aminopyrimidine compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of CK 1, CKIyl, CKIy2, CKIy3, CK2, Pim 1, Pim2, Pim3, the TGFβpathway, the Wnt pathway, the JAK/STAT pathway, the AKT pathway, and/or the mTOR pathway. Uses arc also disclosed for the treatment or prevention of a range of therapeutic indications due at least in part to aberrant physiological activity of CK1, CKIyl, CKIy2, CKIy3, CK2, Pim 1, Pim2, Pim3, the TGFβpathway, the Wnt pathway, the JAK/STAT pathway, the AKT pathway, and/or the mTOR pathway.